Corvus Pharmaceuticals (CRVS): This Clinical-Stage Drugmaker Just Got A Lot More Interesting

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

marketsabout 3 hours ago

Anthropic’s potential $2 trillion IPO comes with the following fine print

Anthropic’s revenue grew over 10-fold in 2025, but the cost of training and serving its models is also climbing.

MarketWatch

marketsabout 5 hours ago

AMD makes a big bet on the next era of AI with World Labs acquisition

The chip maker is buying the startup and adding AI pioneer Fei-Fei Li as its chief scientist.

MarketWatch

marketsabout 7 hours ago

SpaceX’s next big growth engine isn’t rockets — it’s this play on AI power, analysts say

The company has a lucrative opportunity in letting rivals tap its data centers for computing power.

MarketWatch